FluMist Quadrivalent gains tentative approval

Intranasal flu vaccines. Source: US Air Force/Shen-Chia Chu
TGA approves registration of nasal spray which it says could boost uptake of influenza vaccine While AstraZeneca’s FluMist Quadrivalent influenza virus vaccine nasal spray applicator has been registered on the ARTG since 18 October last year, the medicine has been beset with doubts about its effectiveness—especially compared to the injection. In fact, in July 2016

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous No, you shouldn't eat your placenta, here's why
Next Notifications rise